Rani Therapeutics Holdings (RANI) Non-Current Deffered Revenue (2025)
Rani Therapeutics Holdings' Non-Current Deffered Revenue history spans 1 years, with the latest figure at $1.7 million for Q4 2025.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a N/A change, with the full-year FY2025 number at $1.7 million, changed N/A from a year prior.
- Non-Current Deffered Revenue came in at $1.7 million for Q4 2025.
- The five-year high for Non-Current Deffered Revenue was $1.7 million in Q4 2025, with the low at $1.7 million in Q4 2025.